Tocilizumab Contributes to the Inflammatory Status of Mature Dendritic Cells through Interleukin-6 Receptor Subunits Modulation. - Meley D; Héraud A; Gouilleux-Gruart V; Ivanes F; Velge-Roussel F (Frontiers in immunology, 2017)